Scientists Discover Molecule That Can Fight Drug-Resistant Bacteria

Drug resistance has become a hot topic over the last couple of years, and it’s bound to stay that way thanks to a rise in monkeypox and polio cases across the US. This pesky (and sometimes deadly) phenomenon occurs when bacteria, fungi, and other germs become impervious to medication, or even capable of destroying the medication once it’s entered the body. One such bacteria, called Gram-negative bacteria, is responsible for a range of health complications including urinary tract infections (UTIs), lung infections, gastroenteritis, and meningitis.

Gram-negative bacteria owes its resilience to a tough outer cell wall that prevents antibiotics and other treatments from permeating its walls. It also contains a number of efflux pumps, a mechanism by which the bacteria can flush unwanted molecules out of the cell. Together, the cell wall and efflux pumps often render antibiotics ineffective, making uncomfortable and life-threatening health issues difficult to treat. But fabimycin, a newly synthesized compound, appears to permeate Gram-negative bacteria’s defenses enough to let medical treatments do their job.

Fabimycin works by targeting an enzyme called FabI, which is integral to the success of Gram-negative bacteria’s defense mechanisms. While FabI inhibitors have been used to treat staph infections (Staphylococcus aureus), scientists haven’t been able to synthesize one capable of bypassing Gram-negative bacteria’s cell walls—until now. According to new research published in ACS Central Science, a team of chemists and molecular biologists at the University of Illinois at Urbana-Champaign, the Broad Institute of MIT and Harvard, and the Walter Reed Army Institute of Research successfully created fabimycin while working to treat a slew of drug-resistant diseases.

So far, tests have shown that fabimycin is an effective tool in treating over 200 isolated Gram-negative bacterial diseases, including E. coli, a rare case of pneumonia called Klebsiella pneumoniae, and a lung and blood pathogen called Acinetobacter baumannii. Lab-simulated treatments, however, are only as effective as their real-world counterparts. In mice, fabimycin not only helped permeate Gram-negative bacteria but also reduced the concentration of those bacteria to the animals’ pre-infection levels.

The discovery of this powerful compound gives the researchers hope that antibiotics might someday be altered to more effectively target drug-resistant diseases. “Fabimycin has translational promise, and its discovery provides additional evidence that antibiotics can be systematically modified to accumulate in Gram-negative bacteria and kill these problematic pathogens,” the team said.

Continue reading

NASA Discovers Vital Organic Molecule on Titan

In the latest analysis, researchers from NASA have identified an important, highly reactive organic molecule in Titan's atmosphere. Its presence suggests the moon could support chemical processes that we usually associate with life.

Paleontologists Might Have Discovered the Largest Dinosaur That Ever Lived

Scientists excavating a new species of dinosaur in Argentina have reported that the specimen might be the largest that ever lived. Even if it doesn't set a record, the animal was much bigger than anything alive today.

Scientists Can Finally Study Einsteinium 69 Years After Its Discovery

In the remnants of atomic explosions, scientists found never-before-seen elements like einsteinium. Now, almost 70 years after its discovery, scientists have collected enough einsteinium to conduct some basic analysis.

The First Black Hole Ever Discovered Might Be Even Larger

Scientists have been looking for black holes ever since general relativity predicted such an object could exist. Cygnus X-1 made history in 1964 as the first likely candidate black hole. Astronomers have revisited Cygnus over the years, and a new analysis suggests the first black hole spotted by humanity might be larger and farther away than believed.